-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GKQx6Jy0iyfP1DawTa6kjSH3vgPc64Y2K6rNpzrETQN80ZTHeR0gX8CG1g9Rj9K5 5FO73/qWrwbi/FTJRsybmg== 0001264908-05-000003.txt : 20050727 0001264908-05-000003.hdr.sgml : 20050727 20050727090535 ACCESSION NUMBER: 0001264908-05-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050726 FILED AS OF DATE: 20050727 DATE AS OF CHANGE: 20050727 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANGE DAVID L CENTRAL INDEX KEY: 0001264908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 05975620 BUSINESS ADDRESS: STREET 1: 3151 S 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-07-26 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001264908 GRANGE DAVID L 27W 631 SWAN LAKE DRIVE WHEATON IL 60187 1 0 0 0 Common Stock 2005-07-26 4 M 0 3000 25.76 A 4580 D Common Stock 2005-07-26 4 S 0 1200 57.44 D 3380 D Common Stock 2005-07-26 4 S 0 1800 57.45 D 1580 D Stock Options (to buy) 25.76 2005-07-26 4 M 0 3000 0 D 2003-10-15 2013-10-14 Common Stock 3000 15729 D Lisa C. Noecker attorney-in-fact for David Grange 2005-07-27 -----END PRIVACY-ENHANCED MESSAGE-----